| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
HMSA
| Professional | $804,924.78 | $804,924.78 | $804,924.78 | |
Kaiser Permanente
| Professional | $622,455.84 | $679,042.73 | $792,216.52 |
Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
HMSA
| Professional | $804,924.78 | $804,924.78 | $804,924.78 | |
Kaiser Permanente
| Professional | $622,455.84 | $679,042.73 | $792,216.52 |